Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk
factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the …

Cancer patients have an increased risk of cardiovascular disease and, notably, a significant
prevalence of acute coronary syndrome (ACS). It has been shown that an elevated presence …

Cardiovascular (CV) diseases and cancer are the leading causes of death in Europe and
the United States. Both diseases have extensive overlap and share common risk factors …

The underlying aetiopathophysiology of cancer-related strokes and thromboembolisms
differs from that of noncancer-related strokes, which makes treating cancer-related strokes …

It has been shown that patients with cancer have a longer expected life duration, benefiting
from advanced medical therapy. Meanwhile, the risk of suffering from cardiovascular …

Simple Summary Cardiovascular disease and cancer are the leading causes of
hospitalization and mortality in high-income countries. Studies of myocardial infarction show …

The COVID-19 pandemic and its impact on patients with cancer and cardiovascular disease
have confirmed the particular vulnerability of these populations. Indeed, not only a higher …

Monoclonal antibodies (mAB) selectively target leukemia surface antigens and work by
either blocking cell surface receptors or triggering the target cell's destruction. Similarly …

Abstract SCAD (Spontaneous Coronary Artery Dissection) is a rare disorder which rarely
recurs. It is increasingly diagnosed as a cause for acute coronary syndrome (ACS) with …

Background: Myocardial infarction is currently the leading cause of death worldwide,
followed by malignant neoplasms. The presence of both within the same patient obviously …